Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Bosenwel 125 Bosentan Tablets 125 mg
Bosenwel 125 is a dual endothelin receptor antagonist designed to improve blood circulation in pulmonary arteries, reducing symptoms and enhancing exercise capacity in patients with pulmonary arterial hypertension (PAH).
Uses of Bosenwel 125 Bosentan Tablets 125 mg
Treatment of pulmonary arterial hypertension (PAH) to reduce vascular resistance
Management of systemic sclerosis-associated digital ulcers
Benefits of Bosenwel 125 Bosentan Tablets 125 mg
Dual endothelin receptor blockade for maximum efficacy
Improves pulmonary blood flow and oxygenation
Enhances exercise tolerance and quality of life
Delays disease progression in PAH patients
Mechanism of Action of Bosenwel 125 Bosentan Tablets 125 mg
Bosentan selectively blocks endothelin-A (ET-A) and endothelin-B (ET-B) receptors, preventing vasoconstriction and vascular remodeling. This results in vasodilation, reduced pulmonary pressure, and improved cardiac output.